Correlation Between Bristol Myers and Femasys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Femasys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Femasys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Femasys, you can compare the effects of market volatilities on Bristol Myers and Femasys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Femasys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Femasys.

Diversification Opportunities for Bristol Myers and Femasys

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bristol and Femasys is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Femasys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Femasys and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Femasys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Femasys has no effect on the direction of Bristol Myers i.e., Bristol Myers and Femasys go up and down completely randomly.

Pair Corralation between Bristol Myers and Femasys

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.52 times more return on investment than Femasys. However, Bristol Myers Squibb is 1.93 times less risky than Femasys. It trades about 0.1 of its potential returns per unit of risk. Femasys is currently generating about -0.03 per unit of risk. If you would invest  5,135  in Bristol Myers Squibb on October 25, 2024 and sell it today you would earn a total of  574.00  from holding Bristol Myers Squibb or generate 11.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Femasys

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Femasys 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Femasys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Bristol Myers and Femasys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Femasys

The main advantage of trading using opposite Bristol Myers and Femasys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Femasys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Femasys will offset losses from the drop in Femasys' long position.
The idea behind Bristol Myers Squibb and Femasys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios